Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jun;30(6):1479-84.
doi: 10.1128/jcm.30.6.1479-1484.1992.

Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection

Affiliations

Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection

O Meurman et al. J Clin Microbiol. 1992 Jun.

Abstract

The titer and avidity of respiratory syncytial virus-specific antibodies were measured in 196 serum specimens from 93 children with an acute, laboratory-confirmed respiratory syncytial virus infection. An enzyme immunoassay method based on the ability of urea to dissociate the bound antibodies with low avidity from the antigen was used. Three patterns of immune responses were observed. Children less than 6 months of age usually had low titers of antibodies with high avidity in their acute-phase serum samples. These antibodies were concluded to be of maternal origin, since their reaction pattern was similar to that of healthy adults. During the next few weeks, a slight increase in titers with a concurrent decrease in antibody avidity was observed. All children 6 to 24 months of age had low-avidity antibodies in their acute-phase serum samples, which matured to high avidity during the follow-up. On the contrary, about half of the children greater than 24 months of age had high-avidity antibodies already in the acute-phase serum samples. We conclude that the former children were experiencing primary infections with respiratory syncytial virus and the latter were experiencing reinfections. All adults with remote immunity had antibodies with high avidity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1985 Mar;53(3):976-9 - PubMed
    1. J Infect Dis. 1990 Apr;161(4):640-6 - PubMed
    1. J Med Virol. 1984;14(1):67-72 - PubMed
    1. J Med Virol. 1984;14(1):61-5 - PubMed
    1. Pediatr Res. 1983 Sep;17(9):753-8 - PubMed

LinkOut - more resources